Cetrolix SC Injection

Introduction

Cetrolix SC Injection 250 mcg/vial is a synthetic peptide that acts as a gonadotropin-releasing hormone (GnRH) antagonist. It is used in assisted reproduction to control ovarian stimulation and prevent premature ovulation.

Uses

Cetrolix SC Injection 250 mcg/vial is primarily used in assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF). Its main uses include:

Preventing premature luteinizing hormone (LH) surges during ovarian stimulation.
Allowing controlled and optimal timing for egg retrieval.
Enhancing the success rates of ART procedures.

Brand Name	Cetrolix
Type	SC Injection
Weight	250 mcg/vial
Generic	Cetrorelix Acetate
Manufacturer	Eskayef Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Cetrolix SC Injection 250 mcg/vial works by competitively inhibiting the GnRH receptors in the pituitary gland. This action prevents the release of follicle-stimulating hormone (FSH) and LH, thereby suppressing premature ovulation and ensuring that follicle development can be monitored and controlled during ART.

How Long Does It Take to Work?

Cetrolix SC Injection 250 mcg/vial typically begins to work within 24 to 48 hours after administration. Its effects are seen through the suppression of premature LH surges, which helps in the precise control of ovarian stimulation during ART procedures.

Absorption

Cetrolix SC Injection 250 mcg/vial is administered via subcutaneous injection. It is well-absorbed at the injection site, and systemic absorption is generally consistent across individuals.

Route of Elimination

The drug is metabolized primarily by the liver. It is then excreted mainly through the urine. The metabolic pathways and the excretion process ensure the removal of cetrorelix from the system after it has fulfilled its therapeutic role.

Dosage

Cetrorelix Acetate administered subcutaneously once daily (0.25 mg dose) at 24 hour intervals, either in the morning or in the evening as part of the multiple dose protocol during the early-to mid-follicular phase (Day 5/6 to Day11). It is for subcutaneous injection into the lower abdominal wall. The first administration of Cetrorelix Acetate 0.25 mg should be performed under the supervision of a physician. The reconstituted product is to be administered subcutaneously. Use immediately after reconstitution.

The dosage of Cetrolix SC Injection 250 mcg/vial depends on the specific ART protocol. A typical dosage schedule is:

Initial dose: 0.25 mg administered subcutaneously.
Maintenance dose: 0.25 mg administered subcutaneously daily.

Dosage adjustments may be made based on individual patient response and treatment protocol requirements.

Administration

Cetrolix SC Injection 250 mcg/vial is administered as a subcutaneous injection, usually into the abdominal area. Proper injection technique and adherence to the recommended schedule are essential for effective treatment.

Side Effects

Common side effects of Cetrolix SC Injection 250 mcg/vial include:

Injection site reactions such as pain, redness, or swelling.
Headache.
Nausea.
Abdominal pain.

Less common but more serious side effects may include:

Allergic reactions.
Ovarian hyperstimulation syndrome (OHSS).

Toxicity

There is no specific information on acute toxicity for Cetrolix SC Injection 250 mcg/vial. Adverse effects are generally mild and manageable, with severe reactions being rare. Any unusual symptoms should be evaluated by a healthcare provider.

Precautions

Precautions include:

Monitoring for allergic reactions or severe side effects.
Ensuring proper injection technique to avoid complications.
Considering the patient's overall health and ART treatment plan.

Interaction

Cetrolix SC Injection 250 mcg/vial is not known to have significant interactions with other medications. However, it is important to inform healthcare providers of all medications being taken to rule out potential interactions.

Disease Interaction

Patients with liver or kidney impairment may require dose adjustments due to altered metabolism and excretion. It is important to assess and manage any underlying health conditions before starting treatment.

Drug Interaction

There are no significant drug interactions reported for Cetrolix SC Injection 250 mcg/vial. However, always inform the healthcare provider of any concurrent medications or treatments.

Food Interactions

There are no known food interactions with Cetrolix SC Injection 250 mcg/vial. The medication can be administered with or without food.

Pregnancy Use

Cetrolix SC Injection 250 mcg/vial is not used during pregnancy. It is intended for use in women undergoing ART procedures and should not be used in pregnant women due to potential risks.

Lactation Use

The safety of Cetrolix SC Injection 250 mcg/vial during lactation is not well-established. It is generally advised to avoid using the medication while breastfeeding unless the benefits outweigh the risks, as determined by a healthcare provider.

Acute Overdose

Acute overdose of Cetrolix SC Injection 250 mcg/vial is unlikely due to its controlled dosing. In the event of suspected overdose, seek medical attention for appropriate management and evaluation.

Contraindication

Cetrolix SC Injection 250 mcg/vial is contraindicated in individuals with known hypersensitivity to the drug or its components. It should also be avoided in pregnancy and lactation unless specifically advised by a healthcare provider.

Use Direction

Follow the prescribed dosing schedule and administration instructions provided by the healthcare provider. Ensure that injections are administered correctly and adhere to the ART treatment protocol.

Storage Conditions

Cetrolix SC Injection 250 mcg/vial should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the medication in its original packaging and protect it from light until use.

Volume of Distribution

The volume of distribution for Cetrolix SC Injection 250 mcg/vial is not typically specified, as it is used primarily in controlled clinical settings rather than pharmacokinetic studies.

Half Life

The half-life of Cetrolix SC Injection 250 mcg/vial is approximately 2 to 3 hours. This short half-life necessitates daily administration to maintain effective suppression of premature ovulation during ART procedures.

Clearance

Cetrolix SC Injection 250 mcg/vial is cleared from the body primarily through the liver and kidneys. Its clearance rate is consistent with its pharmacokinetic profile, and dose adjustments may be necessary for individuals with hepatic or renal impairment.

See in details version Cetrolix SC Injection 250 mcg/vial also Cetrolix SC Injection 250 mcg/vial in bangla